- US approves first cancer drug to use patient's own cells – with $475,000 price tag https://www.theguardian.com/us-news/2017/aug/30/cancer-drug-kymriah-leukemia-novartis 28 comments worldnews
Linking pages
Linked pages
- Most Americans want universal healthcare. What are we waiting for? | Bernie Sanders | The Guardian https://www.theguardian.com/commentisfree/2017/aug/14/healthcare-a-human-right-bernie-sanders-single-payer-system 43 comments
- Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice | Novartis https://www.novartis.com/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-ctl019 0 comments
Related searches:
Search whole site: site:theguardian.com
Search title: US approves first cancer drug to use patient's own cells – with $475,000 price tag | US healthcare | The Guardian
See how to search.